Medivation, Inc.
Overview
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases. It became a subsidiary of Pfizer Inc. in 2016, enhancing its capabilities in oncology and expanding its portfolio in cancer treatment.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Medivation, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.